Back
AstraZeneca PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
70
AZNCF
AstraZeneca PLC
Last Price:
159.06
Seasonality Move:
4.17%
Sell
48
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.08
Seasonality Move:
-12.6%
Buy
70
AstraZeneca PLC (AZNCF)
is a Buy
Is AstraZeneca PLC a Buy, Sell or Hold?
- The current AstraZeneca PLC [AZNCF] share price is $154.61. The Score for AZNCF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- AZNCF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.10. The Score for ADAP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AZNCF Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $154.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AZNCF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
AZNCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 62.02 | Buy |
| Chaikin Money Flow: | 445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.66 - 154.48) | Buy |
| Bollinger Bands (100): | (127.68 - 144.36) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.02 | Sell |
| Chaikin Money Flow: | 297976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.19) | Sell |
| Bollinger Bands (100): | (0.9 - 1.46) | Sell |
AZNCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.46 | Buy |
| 20-day SMA: | 150.04 | Buy |
| 50-day SMA: | 140.75 | Buy |
| 200-day SMA: | 133.86 | Buy |
| 8-day EMA: | 153.82 | Buy |
| 20-day EMA: | 150 | Buy |
| 50-day EMA: | 143.16 | Buy |
| 200-day EMA: | 135.98 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.15 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.19 | Sell |
| 200-day EMA: | 1.09 | Buy |
AstraZeneca PLC Earnings Growth & AZNCF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
AstraZeneca PLC Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||